Sign In

Credits/Points Offered

  • Continuing Medical Education (CME): 11.50 AMA PRA Category 1 Credits
  • Maintenance of Certification (MOC): 11.50 Points
  • American Board of Pediatrics (ABP): 11.00 MOC points

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Recognize the global epidemiology of NAFLD.
  • Evaluate the strength/limitation of different diagnostic and prognostic modalities of NAFLD.
  • Review the current and future treatment of NAFLD.

Target Audience

  • Hepatologists
  • Gastroenterologists
  • Internists with an interest in metabolic diseases
  • Fellows / Trainees
  • Basic, Translational and Clinical Researchers
  • Industry Representatives

Core Competencies

  • Medical Knowledge
  • Evidence-based Practice
  • Practice-based Learning and Improvement
  • Patient-centered Care

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pediatrics Maintenance of Certification

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 11.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Wednesday, April 19, 2017. A link to the CME evaluation will be emailed to attendees after the meeting.

Certificates will only be issued to those who complete an evaluation by the deadline; requests for CME will not be honored after Wednesday, April 19, 2017. CME certificates will be emailed upon successful completion of the evaluation.

MOC Points

Physicians seeking ABIM and/ or ABP MOC points must complete the CME evaluation and MOC evaluation by Wednesday, April 19, 2017. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation that will be emailed to all attendees, and will remain live until Wednesday, April 19, 2017. MOC points will be reported to the ABIM and ABP by Wednesday, April 26, 2017 for attendees who successfully complete the MOC evaluation.

MOC points will be reported to the ABIM by Wednesday, April 26, 2017 for attendees who successfully complete the MOC pre and post-tests.

Note: CME credit hours and MOC points will not be offered for the following presentations/sessions:

Session V: Oral Presentations

  • VLX103, a New Hepatoselective Investigational Drug Targeting the LPS-TLR4 Pathway in Non-Alcoholic Liver Disease
  • The Comparative Effect of Liraglutide, Elafibranor and Obeticholic Acid on NAFLD Activity Score and Fibrosis Stage in a Diet-Induced Obese Mouse Model of Biopsy-Confirmed Non-Alcoholic Steatohepatitis
  • Poster Reception and Viewing